Xcout Intel
AELIS FARMA competitors & alternatives
The 12 closest competitors and alternatives to AELIS FARMA among biotech companies — ranked by similarity to what AELIS FARMA actually does, not by market-cap band.
Subscribe to see AELIS FARMA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About AELIS FARMA
Aelis Farma is a biopharmaceutical company that develops novel treatments for brain diseases with unmet medical needs. It utilizes a unique class of pharmacological inhibitors, specifically signaling specific inhibitors of the CB1 receptor (CB1-SSi), to target conditions such as cannabis-related disorders and cognitive deficits associated with Down syndrome.
AELIS FARMA at a glance
AELIS FARMA is a biotech company headquartered in France. Xcout tracks 1 named person at AELIS FARMA, including Pier Vincenzo Piazza (CEO).
AELIS FARMA leadership
- Pier Vincenzo PiazzaCEO
Top 12 AELIS FARMA competitors
Ranked by semantic similarity — how close each company is to AELIS FARMA by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
NeuroNascent, Inc. is a privately-held biotechnology and pharmaceutical corporation headquartered in Clarksville, Maryland, focused on developing treatments for diseases such as Alzheimer's and Down syndrome.
Biotechnology
Solvonis Therapeutics plc is a biopharmaceutical company that develops novel medicines for central nervous system (CNS) disorders. Its initial therapeutic focus is on treating Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), with discovery programs extending into broader addiction, psychiatry, and neurology fields.
Biotechnology
Anacalypsis Therapeutics is a biotechnology innovation company based at the Athens Life Tech Park in Greece, focusing on developing medications and biomarkers for central nervous system diseases.
Biotechnology
Syremis Therapeutics Ltd. is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel, dedicated to developing novel drug pipeline medicines targeted at treating diseases of the nervous system and mental health disorders.
Biotechnology
A-Synaptic Corp. is a pharmaceutical company that develops prescriptive topical and transdermal delivery technologies for cannabinoid active pharmaceutical agents. The company primarily focuses on creating cannabinoid-based transdermal treatments for serious conditions, including pediatric epileptic seizures and orphan drug conditions.
Biotechnology
Bloom Science, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, focused on developing novel central nervous system therapies for neurological and metabolic disorders.
Biotechnology
Delix Therapeutics is a privately held biopharmaceutical company headquartered in Boston, Massachusetts, focused on transforming the treatment of brain health through neuroscience.
Similar biotech company
Aelin Therapeutics is a biopharmaceutical company based in Leuven, Belgium, that develops peptide-based novel drug modalities and biotherapeutic technology platforms designed to induce functional knockdown of target proteins through protein aggregation.
Biotechnology
Gate2Brain is a biotechnology company dedicated to developing therapeutics that can efficiently cross biological barriers, such as the blood-brain barrier. It was founded as a spin-off from IRB Barcelona, the University of Barcelona, and Hospital Sant Joan de Déu.
Life Sciences (Therapeutics)
Eumentis Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to developing novel therapies for serious neuropsychiatric conditions.
Biotechnology
Ignis Therapeutics is a biotechnology company established in late 2020 and headquartered in Shanghai, China. The company is dedicated to discovering and developing therapeutics for central nervous system (CNS) diseases.
Biotechnology
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of AELIS FARMA and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for AELIS FARMAand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →